Search Results - "Goergen, Helen"

Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group by Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S, Schäfer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josée M, Keller, Ulrich Bernd, Krause, Stefan W, Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Dührsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter, Engert, Andreas

“…Combined-modality treatment (CMT) with 2× ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and small-field radiotherapy is standard of care for…”
Get full text

Gonadal Function and Fertility in Survivors After Hodgkin Lymphoma Treatment Within the German Hodgkin Study Group HD13 to HD15 Trials by BEHRINGER, Karolin, MUELLER, Horst, REINERS, Katrin S, SCHOBER, Thomas, RENNO, Jorg H, WOLFF, Michael Von, DER VEN, Katrin Van, KUEHR, Marietta, FUCHS, Michael, DIEHL, Volker, ENGERT, Andreas, BORCHMANN, Peter, GOERGEN, Helen, THIELEN, Indra, EIBL, Angelika Diana, STUMPF, Volker, WESSELS, Carsten, WIEHLPÜTZ, Martin, ROSENBROCK, Johannes, HALBSGUTH, Teresa

“…To optimize fertility advice in patients with Hodgkin lymphoma (HL) before therapy and during survivorship, information on the impact of chemotherapy is…”
Get full text

Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group by Kreissl, Stefanie, MD, Mueller, Horst, PhD, Goergen, Helen, Dipl-Math, Mayer, Axel, PhD, Brillant, Corinne, PhD, Behringer, Karolin, MD, Halbsguth, Teresa Veronika, MD, Hitz, Felicitas, MD, Soekler, Martin, MD, Shonukan, Oluwatoyin, MD, Rueffer, Jens Ulrich, MD, Flechtner, Hans-Henning, MD, Fuchs, Michael, MD, Diehl, Volker, MD, Engert, Andreas, MD, Borchmann, Peter, Dr

“…Summary Background Patients with Hodgkin's lymphoma might have persistent fatigue even years after treatment. However, knowledge of the development of fatigue…”
Get full text

Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial by Voltin, Conrad-Amadeus, Mettler, Jasmin, van Heek, Lutz, Goergen, Helen, Müller, Horst, Baues, Christian, Keller, Ulrich, Meissner, Julia, Trautmann-Grill, Karolin, Kerkhoff, Andrea, Fuchs, Michael, Sasse, Stephanie, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter, Engert, Andreas, Kobe, Carsten, Bröckelmann, Paul J

“…A primary analysis of the ongoing NIVAHL trial demonstrated unexpectedly high interim complete response rates to nivolumab-based first-line treatment in…”
Get full text

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial by Behringer, Karolin, MD, Goergen, Helen, Dipl Math, Hitz, Felicitas, MD, Zijlstra, Josée M, MD, Greil, Richard, MD, Markova, Jana, MD, Sasse, Stephanie, MD, Fuchs, Michael, MD, Topp, Max S, MD, Soekler, Martin, MD, Mathas, Stephan, MD, Meissner, Julia, MD, Wilhelm, Martin, MD, Koch, Peter, MD, Lindemann, Hans-Walter, MD, Schalk, Enrico, MD, Semrau, Robert, MD, Kriz, Jan, MD, Vieler, Tom, MD, Bentz, Martin, MD, Lange, Elisabeth, MD, Mahlberg, Rolf, MD, Hassler, Andre, MD, Vogelhuber, Martin, MD, Hahn, Dennis, MD, Mezger, Jörg, MD, Krause, Stefan W, MD, Skoetz, Nicole, MD, Böll, Boris, MD, von Tresckow, Bastian, MD, Diehl, Volker, MD, Hallek, Michael, MD, Borchmann, Peter, MD, Stein, Harald, MD, Eich, Hans, MD, Engert, Andreas, Dr

“…Summary Background The role of bleomycin and dacarbazine in the ABVD regimen (ie, doxorubicin, bleomycin, vinblastine, and dacarbazine) has been questioned,…”
Get full text

Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience by Rothe, Achim, Sasse, Stephanie, Goergen, Helen, Eichenauer, Dennis A., Lohri, Andreas, Jäger, Ulrich, Bangard, Christopher, Böll, Boris, von Bergwelt Baildon, Michael, Theurich, Sebastian, Borchmann, Peter, Engert, Andreas

“…The CD30-targeting Ab-drug conjugate brentuximab vedotin (SGN-35) was recently approved for the treatment of relapsed Hodgkin lymphoma and anaplastic…”
Get full text

Relapsed Hodgkin Lymphoma in Older Patients: A Comprehensive Analysis From the German Hodgkin Study Group by BÖLL, Boris, GOERGEN, Helen, BEHRINGER, Karolin, KLIMM, Beate C, NAUMANN, Ralph, DIEHL, Volker, ENGERT, Andreas, BORCHMANN, Peter, ARNDT, Nils, MEISSNER, Julia, KRAUSE, Stefan W, SCHNELL, Roland, VON TRESCKOW, Bastian, EICHENAUER, Dennis A, SASSE, Stephanie, FUCHS, Michael

“…Progression or relapse of Hodgkin lymphoma (HL) is common among older patients. However, prognosis and effects of second-line treatment are thus far unknown…”
Get full text

Suicide in European Hodgkin Lymphoma Patients by Kim, Austin I., Goergen, Helen, Engert, Andreas, LaCasce, Ann S., Maranda, Louise, Barton, Bruce, Borchmann, Sven

“…The purpose of this study was to determine whether there is an increased risk of suicide in European Hodgkin Lymphoma (HL) patients compared to the general…”
Get full text

Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow‐up of 30 Patients Treated Within the CheckMate 205 Trial in a Single‐Center by Momotow, Jesko, Goergen, Helen, Behringer, Karolin, Bröckelmann, Paul J., Borchmann, Sven, Tresckow, Bastian v., Kobe, Carsten, Engert, Andreas, Sasse, Stephanie

Get full text

The Phase 3 Study ECHELON‐1 Evaluating Brentuximab Vedotin in Patients With Newly Diagnosed Hodgkin Lymphoma Leaves Important Questions Unanswered by Borchmann, Peter, Fosså, Alexander, Długosz‐Danecka, Monika, Böll, Boris, Dietlein, Markus, Kobe, Carsten, Goergen, Helen, Engert, Andreas

Get full text

Reduced‐Intensity Chemotherapy in Patients With Advanced‐Stage Hodgkin Lymphoma by Engert, Andreas, Goergen, Helen, Markova, Jana, Pabst, Thomas, Meissner, Julia, Zijlstra, Josée M., Král, Zdenek, Eichenauer, Dennis A., Soekler, Martin, Greil, Richard, Kreissl, Stefanie, Scheuvens, Ruth, Eich, Hans, Kobe, Carsten, Dietlein, Markus, Stein, Harald, Fuchs, Michael, Diehl, Volker, Borchmann, Peter

“…The international, randomized phase 3 HD15 trial established 6xeBEACOPP as standard therapy for patients with newly diagnosed advanced‐stage Hodgkin lymphoma…”
Get full text

The treatment of older Hodgkin lymphoma patients by Böll, Boris, Görgen, Helen

“…Summary The outcome of patients with Hodgkin lymphoma (HL) has dramatically improved over the past decades and continues to improve with the development of…”
Get full text

Reply to H.J.A. Adams et al by Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Borchmann, Peter, Engert, Andreas

Get full text

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group by Borchmann, Peter, Goergen, Helen, Kobe, Carsten, Lohri, Andreas, Greil, Richard, Eichenauer, Dennis A, Zijlstra, Josée M, Markova, Jana, Meissner, Julia, Feuring-Buske, Michaela, Hüttmann, Andreas, Dierlamm, Judith, Soekler, Martin, Beck, Hans-Joachim, Willenbacher, Wolfgang, Ludwig, Wolf-Dieter, Pabst, Thomas, Topp, Max S, Hitz, Felicitas, Bentz, Martin, Keller, Ulrich Bernd, Kühnhardt, Dagmar, Ostermann, Helmut, Schmitz, Norbert, Hertenstein, Bernd, Aulitzky, Walter, Maschmeyer, Georg, Vieler, Tom, Eich, Hans, Baues, Christian, Stein, Harald, Fuchs, Michael, Kuhnert, Georg, Diehl, Volker, Dietlein, Markus, Engert, Andreas

“…The intensive polychemotherapy regimen eBEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone in escalated…”
Get full text

Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials by Sasse, Stephanie, Bröckelmann, Paul J, Goergen, Helen, Plütschow, Annette, Müller, Horst, Kreissl, Stefanie, Buerkle, Carolin, Borchmann, Sven, Fuchs, Michael, Borchmann, Peter, Diehl, Volker, Engert, Andreas

“…Purpose Combined-modality treatment is widely considered the standard of care in early-stage Hodgkin lymphoma (HL), and treatment intensity has been reduced…”
Get full text

Pretreatment Vitamin D Deficiency Is Associated With Impaired Progression-Free and Overall Survival in Hodgkin Lymphoma by Borchmann, Sven, Cirillo, Melita, Goergen, Helen, Meder, Lydia, Sasse, Stephanie, Kreissl, Stefanie, Bröckelmann, Paul Jan, von Tresckow, Bastian, Fuchs, Michael, Ullrich, Roland Tillmann, Engert, Andreas

“…Vitamin D deficiency is described as a modifiable risk factor for the incidence of and mortality in many common cancers; however, data in Hodgkin lymphoma (HL)…”
Get full text

The Interplay Between Cancer-Related Fatigue and Functional Health in Hodgkin Lymphoma Survivors by Stadtbaeumer, Nele, Müller, Horst, Goergen, Helen, Kreissl, Stefanie, Borchmann, Peter, Mayer, Axel

“…Objective: Cancer-related fatigue (CRF) is among the most distressing symptoms reported by cancer survivors as compromising their quality of life. This study…”
Get full text

Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial by Bröckelmann, Paul J, Goergen, Helen, Keller, Ulrich, Meissner, Julia, Ordemann, Rainer, Halbsguth, Teresa V, Sasse, Stephanie, Sökler, Martin, Kerkhoff, Andrea, Mathas, Stephan, Hüttmann, Andreas, Bormann, Matthias, Zimmermann, Andreas, Mettler, Jasmin, Fuchs, Michael, von Tresckow, Bastian, Baues, Christian, Rosenwald, Andreas, Klapper, Wolfram, Kobe, Carsten, Borchmann, Peter, Engert, Andreas

“…In early-stage unfavorable classic Hodgkin lymphoma (cHL), conventional therapy induces high cure rates but also relevant acute and long-term toxic effects…”
Get more information

Involved-Field Radiation Therapy Prevents Recurrences in the Early Stages of Hodgkin Lymphoma in PET-Negative Patients After ABVD Chemotherapy: Relapse Analysis of GHSG Phase 3 HD16 Trial by Baues, Christian, Goergen, Helen, Fuchs, Michael, Rosenbrock, Johannes, Celik, Eren, Eich, Hans, Kobe, Carsten, Voltin, Conrad-Amadeus, Engert, Andreas, Borchmann, Peter, Marnitz, Simone

“…The HD16 trial of the German Hodgkin Study Group (NCT00736320) demonstrated that radiation therapy in early-stage Hodgkin lymphoma without risk factors cannot…”
Get full text

Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group by Kreissl, Stefanie, Müller, Horst, Goergen, Helen, Meissner, Julia, Topp, Max, Sökler, Martin, Markova, Jana, Bernhard, Jürg, Greil, Richard, von Tresckow, Bastian, Behringer, Karolin, Rüffer, Jens-Ulrich, Flechtner, Hans-Henning, Möstl, Michaela, Fuchs, Michael, Engert, Andreas, Diehl, Volker, Borchmann, Peter

“…Many important details of health-related quality of life (HRQoL) after diagnosis and treatment of Hodgkin lymphoma (HL) are still unknown because large…”
Get full text